Overcoming barriers to optimal use of RWE in HTA with a repository of evidence: an interview with Linda Murphy, Lumanity

Building trust in the quality and acceptability of real-world evidence (RWE) and data (RWD) is key to broadening their use by health technology assessment (HTA) agencies in reimbursement decisions. Efforts are underway across the board to ensure RWD and RWE meet the exemplary standards required by stakeholders when assessing the true value of new medicines. In this interview, we speak with Linda Murphy (Lumanity) about a proposed new repository for RWD/RWE to learn about its creation, development and potential uses. Please could you introduce yourself and your organization? My name is Linda Murphy, I am a Senior Director in HEOR...